In addition, MTDH expression significantly increased in the relapsed MM patients from Total Therapy 2 (TT2) cohort compared to newly diagnosed patients in the same cohort (Figure 1C) [15]. The gene discussed is MTDH; the disease is Miyoshi myopathy.